CYMBALTA Side Effects

7023496-8 | Crying, Disturbance In Attention, Dizziness, Insomnia, Irritability, Lethargy, Muscle Spasms, Paraesthesia
on Sep 29, 2010 Female patient from UNITED STATES , 29 years of age, weighting 185.0 lb, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: crying, disturbance in attention, dizziness (What is dizziness?), insomnia, irritability, lethargy, muscle spasms, paraesthesia. Cymbalta dosage: 40mg 14 Days Po ; 20 Mg 14 Days -weaning- Po.

7022246-9 | Pyrexia, Rash
Patient was taking Cymbalta (View Usage). Patient had the following side effects: pyrexia, rash (What is rash?) on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 43 years of age, was diagnosed with depression (What is depression?) and. Cymbalta dosage: 20 Mg, Daily (1/d). During the same period patient was treated with CYANAMIDE (View Cyanamide Review and Cyanamide Label ). Patient was hospitalized.

7022245-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Adverse event was reported on Sep 17, 2010 by a Male patient taking Cymbalta (View Usage) (Dosage: 30 Mg, Daily (1/d)) was diagnosed with anxiety (What is anxiety?) and. Location: UNITED STATES , 61 years of age, After Cymbalta was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (40 Mg, Daily (1/d)) (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Daily (1/d)) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

7022243-3 | Hepatic Enzyme Increased, Pancreatic Enzymes Increased
on Sep 17, 2010 Female patient from FRANCE , 60 years of age, was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, pancreatic enzymes increased. Cymbalta dosage: .


7022241-X | Asthenia, Dyspnoea, Off Label Use, Oxygen Saturation Decreased, Tremor
on Sep 17, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with neuralgia and was treated with Cymbalta (View Usage). Patient had the following side effects: asthenia, dyspnoea, off label use, oxygen saturation decreased, tremor. Cymbalta dosage: 20 Mg, 3/d. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), LASIX (View Lasix Review and Lasix Label ).

7022240-8 | Dizziness Postural, Fall
Patient was taking Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: dizziness postural, fall (What is fall?) on Sep 17, 2010 from JAPAN Additional patient health information: Male patient , 38 years of age, weighting 198.4 lb, was diagnosed with depression (What is depression?) and. Cymbalta dosage: 20 Mg, Daily (1/d). During the same period patient was treated with LEXOTAN (4 Mg, Daily (1/d)) (View Lexotan Review and Lexotan Label ), RESLIN (50 Mg, Daily (1/d)) (View Reslin Review and Reslin Label ), ROHYPNOL (2 Mg, Daily (1/d)) (View Rohypnol Review and Rohypnol Label ).

7022233-0 | Platelet Count Decreased
Adverse event was reported on Sep 17, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: ) . Location: JAPAN , 75 years of age, Patient experienced the following unwanted or unexpected effects: platelet count decreased. During the same period patient was treated with PREDONINE (Unk, Unk) (View Predonine Review and Predonine Label ), MEILAX (View Meilax Review and Meilax Label ), SEDIEL (View Sediel Review and Sediel Label ).

7022215-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on Sep 17, 2010 Male patient from AUSTRIA , 31 years of age, was treated with Cymbalta (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Cymbalta dosage: 90 Mg, Unk. During the same period patient was treated with ABILIFY (30 D/f, Unk) (View Abilify Review and Abilify Label ), ZELDOX (60 Unk, Unk) (View Zeldox Review and Zeldox Label ), TRAZODONE HCL (50 Unk, Unk) (View Trazodone Hcl Review and Trazodone Hcl Label ).

7020311-3 | Interstitial Lung Disease, Off Label Use
on Sep 16, 2010 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with glossodynia and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: interstitial lung disease, off label use. Cymbalta dosage: 20 Mg, Daily (1/d). During the same period patient was treated with MEILAX (0.5 Mg, Daily (1/d)) (View Meilax Review and Meilax Label ), DOGMATYL (50 Mg, 3/d) (View Dogmatyl Review and Dogmatyl Label ).

7020309-5 | Dysphagia, Gastrointestinal Tube Insertion, Hospitalisation
Patient was taking Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, gastrointestinal tube insertion, hospitalisation on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with major depression and. Cymbalta dosage: 20 Mg, Daily (1/d). Patient was hospitalized.

7020306-X | Haemorrhage
Adverse event was reported on Sep 16, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: haemorrhage.

7020305-8 | Abdominal Pain Upper, Blood Pressure Decreased, Mood Swings, Off Label Use, Palpitations
on Sep 16, 2010 Female patient from GERMANY , 55 years of age, was diagnosed with pain (What is pain?) and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: abdominal pain upper, blood pressure decreased, mood swings, off label use, palpitations. Cymbalta dosage: . During the same period patient was treated with FLUOXETINE HCL (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ).

7020303-4 | Hepatic Function Abnormal
on Sep 16, 2010 Female patient from JAPAN , weighting 183.0 lb, was diagnosed with depression (What is depression?), anxiety (What is anxiety?), vitamin supplementation and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Cymbalta dosage: 20 Mg, Daily (1/d). During the same period patient was treated with PAXIL (20 Mg, Daily (1/d)) (View Paxil Review and Paxil Label ), DEPAKENE (200 Mg, 2/d) (View Depakene Review and Depakene Label ), SILECE (1 Mg, Daily (1/d)) (View Silece Review and Silece Label ), MEILAX (1 Mg, Daily (1/d)) (View Meilax Review and Meilax Label ), GLYSENNID (12 Mg, 2/d) (View Glysennid Review and Glysennid Label ), JUVELA N (200 Mg, 3/d) (View Juvela N Review and Juvela N Label ). Patient was hospitalized.

7020298-3 | Hypoglycaemia
Patient was taking Cymbalta (View Usage). Patient had the following side effects: hypoglycaemia on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , 31 years of age, was diagnosed with diabetic neuropathy, diabetes mellitus and. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

7017904-6 | Chronic Obstructive Pulmonary Disease, Liver Function Test Abnormal
Adverse event was reported on Sep 15, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 65 years of age, After Cymbalta was administered, patient had the following side effects: chronic obstructive pulmonary disease, liver function test abnormal. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), ABILIFY (5 Mg, Unk) (View Abilify Review and Abilify Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIUM (View Calcium Review and Calcium Label ). Patient was hospitalized.

7017902-2 | Constipation, Hepatic Steatosis
on Sep 15, 2010 Female patient from UNITED STATES , 64 years of age, was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), hepatic steatosis. Cymbalta dosage: 30 Mg, Unk. During the same period patient was treated with PAXIL (View Paxil Review and Paxil Label ), OPIOIDS (View Opioids Review and Opioids Label ).

7016788-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise, Nausea
on Sep 14, 2010 Female patient from AUSTRIA , 42 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise, nausea (What is nausea?). Cymbalta dosage: 30 Mg, Daily (1/d). During the same period patient was treated with CONCOR (2.5 Mg, Unk) (View Concor Review and Concor Label ), DOMINAL (80 Mg, Unk) (View Dominal Review and Dominal Label ), POLYETHYLENE GLYCOL (View Polyethylene Glycol Review and Polyethylene Glycol Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ).

7014554-2 | Dizziness, Headache, Hyperhidrosis, Mydriasis, Palpitations, Panic Reaction, Photophobia, Pupils Unequal, Somnolence
Patient was taking Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), hyperhidrosis, mydriasis, palpitations, panic reaction, photophobia, pupils unequal, somnolence on Sep 24, 2010 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 170.0 lb, was diagnosed with fibromyalgia and. Cymbalta dosage: 30mg Once Daily Po.

7014410-X | Pyelonephritis
Adverse event was reported on Sep 14, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: 60 Mg, Daily (1/d)) was diagnosed with depression (What is depression?), contraception and. Location: UNITED STATES , weighting 143.5 lb, Patient experienced the following unwanted or unexpected effects: pyelonephritis. During the same period patient was treated with PARAGARD T 380A (View Paragard T 380a Review and Paragard T 380a Label ), GALENIC /DOCUSATE/SENNA/ (Unk, 2/d) (View Galenic /docusate/senna/ Review and Galenic /docusate/senna/ Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Daily (1/d)) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), FERROUS SULFATE (325 Mg, 2/d) (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

7014391-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Sep 14, 2010 Female patient from FRANCE , 53 years of age, was treated with Cymbalta (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Cymbalta dosage: 60 Mg, Daily (1/d).

7012201-7 | Aspartate Aminotransferase Increased, Blood Creatinine Increased, Glomerular Filtration Rate Decreased
on Sep 10, 2010 Female patient from GERMANY , 39 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: aspartate aminotransferase increased, blood creatinine increased, glomerular filtration rate decreased. Cymbalta dosage: 90 Mg, Daily (1/d). During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PENTASA (View Pentasa Review and Pentasa Label ).

7012199-1 | International Normalised Ratio Increased
Patient was taking Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: international normalised ratio increased on Sep 13, 2010 from GERMANY Additional patient health information: Female patient , 45 years of age, weighting 244.7 lb, was diagnosed with depression (What is depression?) and. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with ATOSIL (125 Mg, Daily (1/d)) (View Atosil Review and Atosil Label ), PANTOPRAZOLE SODIUM (40 Mg, Daily (1/d)) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ZOLPIDEM TARTRATE (20 Mg, Daily (1/d)) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

7012198-X | Brain Neoplasm, Hydrocephalus, Macrocephaly
Adverse event was reported on Sep 13, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: 60 Mg, Daily (1/d)) was diagnosed with depression (What is depression?) and. Location: BELGIUM , weighting 6.42 lb, Patient had the following side effects: brain neoplasm, hydrocephalus (What is hydrocephalus?), macrocephaly. During the same period patient was treated with OMNIBIONTA (Unk, Daily (1/d)) (View Omnibionta Review and Omnibionta Label ).

7011275-7 | Withdrawal Syndrome
on Sep 22, 2010 Female patient from UNITED STATES , 27 years of age, weighting 210.0 lb, was diagnosed with major depression and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: withdrawal syndrome. Cymbalta dosage: 2 Capsules Once Daily Po.

7011064-3 | Acne, Blister, Chest Pain, Energy Increased, Euphoric Mood, Fatigue, Hypersensitivity, Pruritus, Scar
on Sep 22, 2010 Female patient from UNITED STATES , 45 years of age, weighting 142.0 lb, was diagnosed with depression (What is depression?), chronic fatigue syndrome (What is chronic fatigue syndrome?) and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: acne (What is acne?), blister, chest pain (What is chest pain?), energy increased, euphoric mood, fatigue, hypersensitivity, pruritus, scar (What is scar?). Cymbalta dosage: 20 Mg Capsules Once Daily Po. During the same period patient was treated with 5 HOUR ENERGY N/A LIVING ESSENTIALS (5 Hr Engery Same Po Off And On Over 1) (View 5 Hour Energy N/a Living Essentials Review and 5 Hour Energy N/a Living Essentials Label ).

7011062-X | Headache, Nausea, Neck Pain
Patient was taking Cymbalta (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?), neck pain on Sep 22, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 207.0 lb, was diagnosed with neuralgia and. Cymbalta dosage: One Capsyle Daily Po.

7009307-5 | Diabetes Mellitus, Hepatic Enzyme Increased, Jaundice, Urinary Tract Infection
Adverse event was reported on Sep 10, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: ) . Location: UNITED STATES , 83 years of age, After Cymbalta was administered, patient had the following side effects: diabetes mellitus, hepatic enzyme increased, jaundice (What is jaundice?), urinary tract infection (What is urinary tract infection?).

7009304-X | Depressed Level Of Consciousness, Feeling Abnormal, Hypersomnia, Loss Of Consciousness, Malaise, Memory Impairment, Nausea, Off Label Use
on Sep 10, 2010 Female patient from UNITED STATES , 83 years of age, was diagnosed with neuropathy peripheral and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, feeling abnormal, hypersomnia, loss of consciousness, malaise, memory impairment, nausea (What is nausea?), off label use. Cymbalta dosage: 30 Mg, Daily (1/d). During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

7008643-6 | Ventricular Extrasystoles
on Sep 09, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). Patient had the following side effects: ventricular extrasystoles. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with PROTON PUMP INHIBITORS (View Proton Pump Inhibitors Review and Proton Pump Inhibitors Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

7008641-2 | Liver Disorder
Patient was taking Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: liver disorder on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with fibromyalgia and. Cymbalta dosage: 60 Mg, Daily (1/d).

7008618-7 | Acute Hepatic Failure
Adverse event was reported on Sep 09, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: Unk, Daily (1/d)) was diagnosed with depression (What is depression?) and. Location: JAPAN , weighting 106.3 lb, Patient experienced the following unwanted or unexpected effects: acute hepatic failure. During the same period patient was treated with ANAFRANIL (View Anafranil Review and Anafranil Label ). Patient was hospitalized.

7008617-5 | Dermatitis Bullous, Enanthema, Off Label Use, Skin Lesion, Stevens-johnson Syndrome
on Sep 09, 2010 Female patient from FRANCE , 53 years of age, was diagnosed with fibromyalgia and was treated with Cymbalta (View Usage). Patient had the following side effects: dermatitis bullous, enanthema, off label use, skin lesion, stevens-johnson syndrome. Cymbalta dosage: 90 Mg, Daily (1/d). During the same period patient was treated with NORDAZ (View Nordaz Review and Nordaz Label ).

7008611-4 | Blood Alcohol Increased, Gamma-glutamyltransferase Increased, Serum Ferritin Increased, Transaminases Increased
on Sep 09, 2010 Male patient from FRANCE , 50 years of age, was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: blood alcohol increased, gamma-glutamyltransferase increased, serum ferritin increased, transaminases increased. Cymbalta dosage: 30 Mg, Daily (1/d). During the same period patient was treated with ALCOHOL (View Alcohol Review and Alcohol Label ).

7008610-2 | Acute Hepatic Failure, Decreased Appetite
Patient was taking Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, decreased appetite on Sep 09, 2010 from JAPAN Additional patient health information: Female patient , weighting 97.00 lb, was diagnosed with depression (What is depression?) and. Cymbalta dosage: Unk, Unk. During the same period patient was treated with MEILAX (View Meilax Review and Meilax Label ), SOLANAX (View Solanax Review and Solanax Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

7008607-2 | Gamma-glutamyltransferase Increased
Adverse event was reported on Sep 09, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: 40 Mg, Daily (1/d)) was diagnosed with depression (What is depression?) and. Location: JAPAN , 60 years of age, Patient had the following side effects: gamma-glutamyltransferase increased.

7008605-9 | Liver Function Test Abnormal
on Sep 09, 2010 Male patient from JAPAN , 33 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: liver function test abnormal. Cymbalta dosage: .

7005948-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Liver Injury, Ocular Icterus
on Sep 08, 2010 Female patient from UNITED STATES , 56 years of age, was diagnosed with sciatica (What is sciatica?), back pain (What is back pain?) and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, liver injury, ocular icterus. Cymbalta dosage: 30 Mg, Daily (1/d). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

7005944-2 | Acute Hepatic Failure, Mean Cell Haemoglobin, Mean Cell Volume Abnormal, Nausea, Renal Failure
Patient was taking Cymbalta (View Usage). Patient had the following side effects: acute hepatic failure, mean cell haemoglobin, mean cell volume abnormal, nausea (What is nausea?), renal failure on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 37 years of age, was diagnosed with depression (What is depression?), bipolar disorder (What is bipolar disorder?) and. Cymbalta dosage: 1 D/f, As Needed. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE (80 Mg, Daily (1/d)) (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), ABILIFY (15 Mg, Daily (1/d)) (View Abilify Review and Abilify Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), LEVOTHYROXIN 0.05 MG KSA (250 Ug, Daily (1/d)) (View Levothyroxin 0.05 Mg Ksa Review and Levothyroxin 0.05 Mg Ksa Label ). Patient was hospitalized.

7005941-7 | Hepatitis
Adverse event was reported on Sep 08, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: 120 Mg, Daily (1/d)) was diagnosed with depression (What is depression?) and. Location: AUSTRALIA , 35 years of age, After Cymbalta was administered, patient had the following side effects: hepatitis (What is hepatitis?).

7005939-9 | Arthritis, Depression, Glaucoma, Hypoglycaemia, Intraocular Pressure Increased, Morbid Thoughts, Nervousness
on Sep 08, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with depression (What is depression?), sleep disorder (What is sleep disorder?), abdominal pain upper and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), depression (What is depression?), glaucoma (What is glaucoma?), hypoglycaemia, intraocular pressure increased, morbid thoughts, nervousness. Cymbalta dosage: 30 Mg, 2/d. During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), AVARA (View Avara Review and Avara Label ), XANAX (1 Mg, 3/d) (View Xanax Review and Xanax Label ), DALMANE (View Dalmane Review and Dalmane Label ), LORA TAB (View Lora Tab Review and Lora Tab Label ). Patient was hospitalized.

7005938-7 | Hepatic Necrosis, Renal Injury
on Sep 08, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with pain (What is pain?) and was treated with Cymbalta (View Usage). Patient had the following side effects: hepatic necrosis, renal injury. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CONTRACEPTIVES (View Contraceptives Review and Contraceptives Label ). Patient was hospitalized.

7005937-5 | Fibromyalgia, Hepatitis Cholestatic, Hypotension, Paraesthesia, Shoulder Operation
Patient was taking Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: fibromyalgia, hepatitis cholestatic, hypotension, paraesthesia, shoulder operation on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 177.0 lb, was diagnosed with pain (What is pain?), neck pain, insomnia and. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with ARTHROTEC (1 D/f, Each Morning) (View Arthrotec Review and Arthrotec Label ), TRAZODONE HCL (100 Mg, Each Evening) (View Trazodone Hcl Review and Trazodone Hcl Label ), COLACE (100 Mg, Each Evening) (View Colace Review and Colace Label ), OXYCODONE AND ACETAMINOPHEN (1 D/f, Unk) (View Oxycodone And Acetaminophen Review and Oxycodone And Acetaminophen Label ), OXYCODONE HCL (1 D/f, Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), IBUPROFEN (1 D/f, Unk) (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized and became disabled.

7005929-6 | Cholelithiasis, Hepatitis, Overdose
Adverse event was reported on Sep 08, 2010 by a Female patient taking Cymbalta (View Usage) (Dosage: ) . Location: AUSTRALIA , 48 years of age, Patient experienced the following unwanted or unexpected effects: cholelithiasis, hepatitis (What is hepatitis?), overdose.

7005927-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Vulval Abscess
on Sep 08, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with fibromyalgia and was treated with Cymbalta (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, vulval abscess. Cymbalta dosage: 60 Mg, Unk. Patient was hospitalized.

7003300-4 | Hepatic Function Abnormal
on Sep 07, 2010 Female patient from JAPAN , 41 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: hepatic function abnormal. Cymbalta dosage: 60 Mg, Daily (1/d). During the same period patient was treated with PAXIL (20 Mg, Daily (1/d)) (View Paxil Review and Paxil Label ), SILECE (1 Mg, Daily (1/d)) (View Silece Review and Silece Label ), MEILAX (1 Mg, Daily (1/d)) (View Meilax Review and Meilax Label ). Patient was hospitalized.

7003297-7 | Liver Disorder
Patient was taking Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Sep 07, 2010 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with depression (What is depression?) and. Cymbalta dosage: 60 Mg, Daily (1/d).

7003295-3 | Constipation, Haematochezia
Adverse event was reported on Sep 07, 2010 by a Male patient taking Cymbalta (View Usage) (Dosage: 30 Mg, Daily (1/d)) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 22 years of age, Patient had the following side effects: constipation (What is constipation?), haematochezia. During the same period patient was treated with PROZAC (20 Mg, 2/d) (View Prozac Review and Prozac Label ).

6992645-X | Dizziness, Fatigue, Migraine, Paraesthesia
on Sep 16, 2010 Male patient from UNITED STATES , 20 years of age, weighting 135.0 lb, was treated with Cymbalta (View Usage). After Cymbalta was administered, patient had the following side effects: dizziness (What is dizziness?), fatigue, migraine (What is migraine?), paraesthesia. Cymbalta dosage: 90mg Once A Day Po.

6988554-2 | Disorientation, Fall, Head Injury, Speech Disorder
on Sep 03, 2010 Female patient from UNITED STATES , 92 years of age, was diagnosed with depression (What is depression?) and was treated with Cymbalta (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, fall (What is fall?), head injury, speech disorder. Cymbalta dosage: 60 Mg, 2/d. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), PLAVIX (View Plavix Review and Plavix Label ).

6988547-5 | Colitis Collagenous
Patient was taking Cymbalta (View Usage). Patient had the following side effects: colitis collagenous on Sep 03, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 103.0 lb, was diagnosed with depression (What is depression?), hypertension and. Cymbalta dosage: 60 Mg, Unk. During the same period patient was treated with LISINOPRIL (10 Mg, Unk) (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (12.5 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).